Skip to main content
Top
Published in: Current Infectious Disease Reports 6/2015

01-06-2015 | Transplant and Oncology (M Ison and N Theodoropoulos, Section Editors)

The Swiss Transplant Cohort Study: Lessons from the First 6 Years

Authors: Christoph Berger, Pierre-Yves Bochud, Katja Boggian, Alexia Cusini, Adrian Egli, Christian Garzoni, Hans H. Hirsch, Matthias Hoffmann, Nina Khanna, Oriol Manuel, Pascal Meylan, David Nadal, Christian van Delden, Maja Weisser, Nicolas J. Mueller, Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study

Published in: Current Infectious Disease Reports | Issue 6/2015

Login to get access

Abstract

Prospective cohort studies significantly contribute to answering specific research questions in a defined population. Since 2008, the Swiss Transplant Cohort Study (STCS) systematically enrolled >95 % of all transplant recipients in Switzerland, collecting predefined data at determined time points. Designed as an open cohort, the STCS has included >3900 patients to date, with a median follow-up of 2.96 years (IQR 1.44–4.73). This review highlights some relevant findings in the field of transplant-associated infections gained by the STCS so far. Three key general aspects have crystallized: (i) Well-run cohort studies are a powerful tool to conduct genetic studies, which are crucially dependent on a meticulously described phenotype. (ii) Long-term real-life observations are adding a distinct layer of information that cannot be obtained during randomized studies. (iii) The systemic collection of data, close interdisciplinary collaboration, and continuous analysis of some key outcome data such as infectious diseases endpoints can improve patient care.
Literature
1.
2.
go back to reference Burkhalter H, Wirz-Justice A, Cajochen C, et al. Validation of a single item to assess daytime sleepiness for the Swiss Transplant Cohort Study. Prog Transplant. 2013;23(3):220–8.CrossRefPubMed Burkhalter H, Wirz-Justice A, Cajochen C, et al. Validation of a single item to assess daytime sleepiness for the Swiss Transplant Cohort Study. Prog Transplant. 2013;23(3):220–8.CrossRefPubMed
3.
go back to reference Burkhalter H, Wirz-Justice A, Cajochen C, et al. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. Clin Transpl. 2014;28(1):58–66.CrossRef Burkhalter H, Wirz-Justice A, Cajochen C, et al. Daytime sleepiness in renal transplant recipients is associated with immunosuppressive non-adherence: a cross-sectional, multi-center study. Clin Transpl. 2014;28(1):58–66.CrossRef
4.
go back to reference De Geest S, Burkhalter H, Berben L, et al. The Swiss Transplant Cohort Study’s framework for assessing lifelong psychosocial factors in solid-organ transplants. Prog Transplant. 2013;23(3):235–46.CrossRefPubMed De Geest S, Burkhalter H, Berben L, et al. The Swiss Transplant Cohort Study’s framework for assessing lifelong psychosocial factors in solid-organ transplants. Prog Transplant. 2013;23(3):235–46.CrossRefPubMed
5.
go back to reference De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transplant Int: Off J Eur Soc Organ Transplant. 2014;27(7):657–66. De Geest S, Burkhalter H, Bogert L, et al. Describing the evolution of medication nonadherence from pretransplant until 3 years post-transplant and determining pretransplant medication nonadherence as risk factor for post-transplant nonadherence to immunosuppressives: the Swiss Transplant Cohort Study. Transplant Int: Off J Eur Soc Organ Transplant. 2014;27(7):657–66.
6.
go back to reference Koller MT, van Delden C, Muller NJ, et al. Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol. 2013;28(4):347–55.CrossRefPubMedCentralPubMed Koller MT, van Delden C, Muller NJ, et al. Design and methodology of the Swiss Transplant Cohort Study (STCS): a comprehensive prospective nationwide long-term follow-up cohort. Eur J Epidemiol. 2013;28(4):347–55.CrossRefPubMedCentralPubMed
7.
go back to reference Berger C, Boggian K, Cusini A, et al. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant. 2012;17(6):581–5.CrossRefPubMed Berger C, Boggian K, Cusini A, et al. Relevance of cohort studies for the study of transplant infectious diseases. Curr Opin Organ Transplant. 2012;17(6):581–5.CrossRefPubMed
8.•
go back to reference Bucheli E, Kralidis G, Boggian K, et al. Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study. Transplant Infect Dis. 2014;16(1):26–36. Epidemiological study showing increase in E. faecium infections, but also that colonization rarely results in proven infections.CrossRef Bucheli E, Kralidis G, Boggian K, et al. Impact of enterococcal colonization and infection in solid organ transplantation recipients from the Swiss transplant cohort study. Transplant Infect Dis. 2014;16(1):26–36. Epidemiological study showing increase in E. faecium infections, but also that colonization rarely results in proven infections.CrossRef
9.
go back to reference Stern M, Hirsch H, Cusini A, et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation. 2014;98(9):1013–8.CrossRefPubMed Stern M, Hirsch H, Cusini A, et al. Cytomegalovirus serology and replication remain associated with solid organ graft rejection and graft loss in the era of prophylactic treatment. Transplantation. 2014;98(9):1013–8.CrossRefPubMed
10.•
go back to reference Manuel O, Kralidis G, Mueller NJ, et al. Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2013;13(9):2402–10. Real-life observation of CMV disease and its potential role in graft survival.CrossRefPubMed Manuel O, Kralidis G, Mueller NJ, et al. Impact of antiviral preventive strategies on the incidence and outcomes of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant. 2013;13(9):2402–10. Real-life observation of CMV disease and its potential role in graft survival.CrossRefPubMed
11.•
go back to reference Gonzalez A, Schmitter K, Hirsch HH, et al. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes Immun. 2014;15(7):495–9. Correlation of Killer cell Immunoglobulin-like Receptor (KIR) genes and CMV replication. The study relies on the regular sampling and precise collection of endpoints.CrossRefPubMed Gonzalez A, Schmitter K, Hirsch HH, et al. KIR-associated protection from CMV replication requires pre-existing immunity: a prospective study in solid organ transplant recipients. Genes Immun. 2014;15(7):495–9. Correlation of Killer cell Immunoglobulin-like Receptor (KIR) genes and CMV replication. The study relies on the regular sampling and precise collection of endpoints.CrossRefPubMed
12.
go back to reference Manuel O, Wojtowicz A, Bibert S, et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis. 2015;211:906–14. doi:10.1093/infdis/jiu557 Manuel O, Wojtowicz A, Bibert S, et al. Influence of IFNL3/4 polymorphisms on the incidence of cytomegalovirus infection after solid-organ transplantation. J Infect Dis. 2015;211:906–14. doi:10.1093/infdis/jiu557
13.••
go back to reference Wojtowicz A, Gresnigt MS, Lecompte T, et al. IL1B and DEFB1 polymorphisms increase susceptibility to invasive mold infection after solid-organ transplantation. J Infect Dis. 2014. This study shows the power of numbers, and availability of biological samples, to test a hypothesis. The findings indicate that susceptibility to mold infections is partly genetically determined. Wojtowicz A, Gresnigt MS, Lecompte T, et al. IL1B and DEFB1 polymorphisms increase susceptibility to invasive mold infection after solid-organ transplantation. J Infect Dis. 2014. This study shows the power of numbers, and availability of biological samples, to test a hypothesis. The findings indicate that susceptibility to mold infections is partly genetically determined.
15.
go back to reference Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587–97.CrossRefPubMed Frobert O, Lagerqvist B, Olivecrona GK, et al. Thrombus aspiration during ST-segment elevation myocardial infarction. N Engl J Med. 2013;369(17):1587–97.CrossRefPubMed
16.
go back to reference Frobert O, Lagerqvist B, Gudnason T, et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160(6):1042–8.CrossRefPubMed Frobert O, Lagerqvist B, Gudnason T, et al. Thrombus Aspiration in ST-Elevation myocardial infarction in Scandinavia (TASTE trial). A multicenter, prospective, randomized, controlled clinical registry trial based on the Swedish angiography and angioplasty registry (SCAAR) platform. Study design and rationale. Am Heart J. 2010;160(6):1042–8.CrossRefPubMed
Metadata
Title
The Swiss Transplant Cohort Study: Lessons from the First 6 Years
Authors
Christoph Berger
Pierre-Yves Bochud
Katja Boggian
Alexia Cusini
Adrian Egli
Christian Garzoni
Hans H. Hirsch
Matthias Hoffmann
Nina Khanna
Oriol Manuel
Pascal Meylan
David Nadal
Christian van Delden
Maja Weisser
Nicolas J. Mueller
Transplant Infectious Diseases Working Group, Swiss Transplant Cohort Study
Publication date
01-06-2015
Publisher
Springer US
Published in
Current Infectious Disease Reports / Issue 6/2015
Print ISSN: 1523-3847
Electronic ISSN: 1534-3146
DOI
https://doi.org/10.1007/s11908-015-0486-5

Other articles of this Issue 6/2015

Current Infectious Disease Reports 6/2015 Go to the issue

Healthcare Associated Infections (G Bearman and D Morgan, Section Editors)

The Pros, Cons, and Unknowns of Search and Destroy for Carbapenem-Resistant Enterobacteriaceae

Transplant and Oncology (M Ison and N Theodoropoulos, Section Editors)

Sepsis in the Severely Immunocompromised Patient

Genitourinary Infections (J Sobel, Section Editor)

Vulvovaginal Candidiasis in Pregnancy

Intra-abdominal Infections, Hepatitis, and Gastroenteritis (T Steiner, Section Editor)

Epidemiology and Treatment of Trichomoniasis

Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.